HOME > BUSINESS
BUSINESS
- J-TEC Submits Japan’s First Regenerative Medicine Product in Ophthalmology Field
March 22, 2019
- Mitsubishi Tanabe Sets Up Sales Subsidiary in Malaysia for Independent Marketing
March 22, 2019
- Takeda Taps Neuro-Psychiatric Expert Kajii as T-CiRA Chief
March 22, 2019
- Nippon Shinyaku Licenses Dravet Syndrome Treatment from Zogenix
March 22, 2019
- Chugai, SRL Link Up for Cancer Gene Mutation Tests
March 22, 2019
- Medipal Holdings Invests in Belgium’s Cell Therapy Developer
March 22, 2019
- Gilead Set to Duplicate Biktarvy Success in Japan with New Stand-Alone HIV Sales Force
March 20, 2019
- Daiichi Sankyo’s Edoxaban Demonstrates Efficacy, Safety in AF Patients Undergoing Catheter Ablation
March 20, 2019
- Ono Files Multiple Myeloma Treatment Kyprolis for Once-Weekly Administration Regimen
March 20, 2019
- Servier, Oncodesign Join Forces to Develop Parkinson’s Disease Treatments
March 20, 2019
- NapaJen, Astellas Form Oligonucleotide Research Collaboration
March 19, 2019
- Ono Ties Up with AI Startup twoXAR on Drug Discovery
March 19, 2019
- 9 Month Cost-Effectiveness Analysis Possible If Companies Are Well-Prepared: Crecon Official
March 19, 2019
- Employee Sues Bayer Japan for Emotional Distress over Xarelto Scandal
March 19, 2019
- Hitachi Chemical Aspires to World’s No. 1 Regenerative Medicine CMO by Securing Bases in US, Europe through M&As
March 19, 2019
- Entrectinib Filed in Japan for ROS1 Lung Cancer: Chugai
March 18, 2019
- Alfresa Seeks to Expand Foothold in China via Tie-Up with 2nd Largest Drug Wholesaler
March 18, 2019
- Drug Makers, Wholesalers Establishing Supervisory Divisions as Detailing Guidelines Rollout Nears
March 15, 2019
- Synthetic Rubber Form of Rivastach/Exelon Patch Approved: Ono/Novartis
March 15, 2019
- Aricept Generics Earn Lewy Body Dementia Indications
March 14, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
